Evidence map›Paper›PMID 17592644›Full record

ArticleBMC public health2007

Impact of pharmaceutical promotion on prescribing decisions of general practitioners in Eastern Turkey.

Serhat Vancelik, Nazim E Beyhun, Hamit Acemoglu, Oksan Calikoglu

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 83 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Influence of pharmaceutical promotion on prescribers in Jordan.International journal of clinical pharmacy · 2020
    Article
  8. Article
  9. Article
  10. Ageing, health status and coverage rate effects on community prescription costs in Ireland.The European journal of health economics : HEPAC : health economics in prevention and care · 2018
    Article
  11. Towards Patient-Centered Conflicts of Interest Policy.International journal of health policy and management · 2018
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. General public knowledge, perceptions and practice towards pharmaceutical drug advertisements in the Western region of KSA.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2014
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Serhat VancelikDepartment of Public Health in Ataturk University, School of Medicine, Erzurum, Turkey. svanceli@atauni.edu.tr <svanceli@atauni.edu.tr>
Nazim E Beyhun
Hamit Acemoglu
Oksan Calikoglu
Atatürk University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCommercial sources of information are known to have greater influence than scientific sources on general practitioners' (GPs) prescribing behavior in under developed and developing countries. The study aimed to determine the self-reported impact of pharmaceutical promotion on the decision-making process of prescription of GPs in Eastern Turkey.

methodsA cross-sectional, exploratory survey was performed among 152 GPs working in the primary health centers and hospitals in Erzurum province of Eastern Turkey in 2006. A self-administered structured questionnaire was used. The questionnaire included questions regarding sociodemographics, number of patients per day, time per patient, frequency of sales representative visits to GPs, participation of GPs in training courses on prescribing (in-service training, drug companies), factors affecting prescribing decision, reference sources concerning prescribing and self-reported and self-rated effect of the activities of sales representatives on GPs prescribing decisions.

resultsOf 152 subjects, 53.3% were male and 65.8% were working at primary health care centers, respectively. Mean patient per day was 58.3 +/- 28.8 patients per GP. For majority of the GPs (73.7%), the most frequent resource used in case of any problems in prescribing process was drug guides of pharmaceutical companies. According to self-report of the GPs, their prescribing decisions were affected by participation in any training activity of drug companies, frequent visits by sales representatives, high number of patient examinations per day and low year of practice (p < 0.05 for all).

conclusionThe results of this study suggest that for the majority of the GPs, primary reference sources concerning prescribing was commercial information provided by sales representatives of pharmaceutical companies, which were reported to be highly influential on their decision-making process of prescribing by GPs. Since this study was based on self-report, the influence reported by the GPs may have been underestimated.

Indexed as

MarketingAdultChi-Square DistributionCross-Sectional StudiesDecision MakingDrug CostsDrug IndustryDrug PrescriptionsDrug UtilizationFamily PracticeFemaleHumansMaleMiddle AgedPractice Patterns, Physicians'Surveys and Questionnaires

Identifiers

PMID17592644
PMCPMC1913508
OpenAlexW2089008856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.